Results 161 to 170 of about 10,079,690 (327)

Research Capacity and Culture Development in a Small Rural Health Service. [PDF]

Aust J Rural Health
Pu D, Gill S, Field M, Buccheri A, King OA, Huggins CE, Haines T, Porter JE, Versace VL, Alston L.   +9 more
europepmc   +1 more source

Enhancement of Data Hiding Capacity in Audio Steganography

, 2014
Iosr Journals, Sheelu
openalex   +1 more source

Solving the Stochastic Generation and Transmission Capacity Planning Problem Applied to Large-Scale Power Systems Using Generalized Shift-Factors [PDF]

, 2020
Víctor H. Hinojosa, Joaquín Sepúlveda
openalex   +1 more source

LSC Capacity Building Fund: Final report [PDF]

, 2005

core  

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Strengthening equitable research capacity in response to infectious diseases of poverty. [PDF]

BMJ Glob Health
Asampong E, Echavarria Mejia MI, Mahendradhata Y, Vahedi M, Thorson A.   +4 more
europepmc   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source

Restraint in somatic healthcare: how should it be regulated? [PDF]

J Med Ethics
Guenna Holmgren A, von Vogelsang AC, Lindblad A, Juth N.   +3 more
europepmc   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

Super High Capacity of Lithium Battery Silicon-Carbon Anode over 6,500 mAh g^-1. [PDF]

Research (Wash D C)
Lin S, Yang M, Zhao Z, Zhi M, Bai X, Xiong K.   +5 more
europepmc   +1 more source